Arbutus Biopharma Corp (ABUS) vs SpyGlass Pharma, Inc. Common Stock (SGP)

A side-by-side comparison of Arbutus Biopharma Corp and SpyGlass Pharma, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Arbutus Biopharma Corp logo
ABUS
Arbutus Biopharma Corp
$885M
$4.48HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SpyGlass Pharma, Inc. Common Stock logo
SGP
SpyGlass Pharma, Inc. Common Stock
$828M
$24.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ABUS vs SGP

growth of $100 · dividends reinvested · last 1y
ABUS +13.6% (+13.6%/yr)SGP -3.1% (-3.1%/yr)ABUS compounded faster over this window
80100120Start $100$114$97
ABUS SGP

ABUS vs SGP: by the numbers

  • •ABUS is the larger company ($885M vs $828M market cap).
  • •ABUS is profitable (84.23% net margin) while SGP runs a net loss (0.00%).

Metrics side by side

Valuation

MetricABUSSGP
P/E ratio5.74N/A
Forward P/E6.05N/A
P/S ratio4.87N/A
P/B ratio3.423.57
EV / EBITDA5.90N/A

Profitability

MetricABUSSGP
Gross margin99.98%0.00%
Operating margin-192.08%0.00%
Net margin84.23%0.00%
ROE59.16%-24.12%
ROIC54.39%-26.54%

Growth (annualized)

MetricABUSSGP
Revenue CAGR (5Y)85.17%N/A
Total return CAGR (5Y)2.19%N/A

Frequently asked

Is ABUS or SGP more profitable?
ABUS runs the higher net margin — ABUS at 84.23% versus SGP at 0.00%.

Go deeper

Full ABUS analysisFull SGP analysisInteractive comparison tool

Dig into the metrics

Arbutus Biopharma P/E ratioArbutus Biopharma ROESpyGlass Pharma, Inc. Common Stock ROEArbutus Biopharma operating marginSpyGlass Pharma, Inc. Common Stock operating marginArbutus Biopharma revenue growthSpyGlass Pharma, Inc. Common Stock revenue growthArbutus Biopharma free cash flowSpyGlass Pharma, Inc. Common Stock free cash flow

Arbutus Biopharma & SpyGlass Pharma, Inc. Common Stock appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.